Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07870057 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Innovative Approaches to Identify Causative Genetic Variants in Patients With Unexplained Bleeding Disorders

Study acronym: UNEX-EMO 2022
StatusCompleted
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Collaborators revised (2)
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Creation of an Italian network for unexplained bleeding disorders, using integrated multi-omics approaches to improve diagnosis, optimize patient management, and identify novel therapeutic targets.
Trial Details
NCT Number NCT07870057
Lead Sponsor Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Collaborators: Istituto Clinico Humanitas, Policlinico di Bari Giovanni XXIII
Conditions
(from sponsor)		 PATIENTS WITH UNEXPLAINED BLEEDING DISORDERS
Related terms Hemostatic Disorders
Enrollment 122 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov